Milk basic protein

Last updated

Milk basic protein (MBP) is a fraction of whey protein found in milk. [1] Separated from milk through the process of fractionation, it is a functional compound [2] and consists of several milk proteins which are biologically active. The composition is approximately 54% lactoferrin and 41% lactoperoxidase, [3] with other active proteins, such as Cyastin C and high mobility group-like proteins, making up the remainder of the fraction. [4] MBP has been evaluated for safety and is intended for use as a dietary ingredient. [3] It is approved in Japan as a functional food ingredient in tofu and nattō. [5]

Whey protein

Whey protein is a mixture of proteins isolated from whey, the liquid material created as a by-product of cheese production. The proteins consist of α-lactalbumin, β-lactoglobulin, serum albumin and immunoglobulins. Whey protein is commonly marketed as a dietary supplement, and various health claims have been attributed to it. An authoritative review published in 2010 concluded that the provided literature did not adequately support the proposed claims.

Fractionation

Fractionation is a separation process in which a certain quantity of a mixture is divided during a phase transition, into a number of smaller quantities (fractions) in which the composition varies according to a gradient. Fractions are collected based on differences in a specific property of the individual components. A common trait in fractionations is the need to find an optimum between the amount of fractions collected and the desired purity in each fraction. Fractionation makes it possible to isolate more than two components in a mixture in a single run. This property sets it apart from other separation techniques.

Lactoferrin protein-coding gene in the species Homo sapiens

Lactoferrin (LF), also known as lactotransferrin (LTF), is a multifunctional protein of the transferrin family. Lactoferrin is a globular glycoprotein with a molecular mass of about 80 kDa that is widely represented in various secretory fluids, such as milk, saliva, tears, and nasal secretions. Lactoferrin is also present in secondary granules of PMNs and is secreted by some acinar cells. Lactoferrin can be purified from milk or produced recombinantly. Human colostrum has the highest concentration, followed by human milk, then cow milk (150 mg/L).

Contents

Biological function

Active substances in the milk basic protein fraction promote bone formation and suppress bone resorption. It has been found to decrease the formation of osteoclast pits, which act to break down bone and release minerals for resorption into plasma, MBP helps to reduce this process. [1] It also increases bone mineralization by stimulating proliferation of osteoblasts which are involved in collagen production and bone formation. [6] Daily supplementation with 40 mg of MBP over 6 months has been shown to result in increased bone mineral density and lower urinary markers of bone resorption. [1]

Osteoclast type of bone cell that breaks down bone tissue

An osteoclast is a type of bone cell that breaks down bone tissue. This function is critical in the maintenance, repair, and remodelling of bones of the vertebral skeleton. The osteoclast disassembles and digests the composite of hydrated protein and mineral at a molecular level by secreting acid and a collagenase, a process known as bone resorption. This process also helps regulate the level of blood calcium.

Resorption is the absorption into the circulatory system of cells or tissue, usually by osteoclasts.

Clinical relevance

It has been found to have a role in the prevention and treatment of osteoporosis. [7] Direct effects have been identified between MBP and strengthening of bones, through its influences on bone remodelling (formation and resorption) and enhancement bone mineral density. [6] These actions may be beneficial for pre-menopausal and menopausal women in particular, as increased bone mineral density decreases the risk of fractures associated with osteoporosis.

Osteoporosis bone resorption disease characterized by decreased density of normally mineralized bone which results in the thinning of bone tissue and decreased mechanical strength

Osteoporosis is a disease in which bone weakening increases the risk of a broken bone. It is the most common reason for a broken bone among the elderly. Bones that commonly break include the vertebrae in the spine, the bones of the forearm, and the hip. Until a broken bone occurs there are typically no symptoms. Bones may weaken to such a degree that a break may occur with minor stress or spontaneously. Chronic pain and a decreased ability to carry out normal activities may occur following a broken bone.

Allergen Labeling

Previous studies have concluded that "the protein components in MBP are unlikely to present any increased risk of allergy for milk allergic subjects or of cross-reactivity for other allergic subjects" (Goodman et al. 2007, p. 1787). However, the United States of America and the European Union have not deemed it to be free of milk allergens. Therefore, any products containing milk basic protein fractions as ingredients are identified as containing milk under the food labelling guidelines set forth by the United States of America and European Union to alert consumers. [4]

Related Research Articles

Calcium Chemical element with atomic number 20

Calcium is a chemical element with symbol Ca and atomic number 20. As an alkaline earth metal, calcium is a reactive metal that forms a dark oxide-nitride layer when exposed to air. Its physical and chemical properties are most similar to its heavier homologues strontium and barium. It is the fifth most abundant element in Earth's crust and the third most abundant metal, after iron and aluminium. The most common calcium compound on Earth is calcium carbonate, found in limestone and the fossilised remnants of early sea life; gypsum, anhydrite, fluorite, and apatite are also sources of calcium. The name derives from Latin calx "lime", which was obtained from heating limestone.

Dietary supplement product that provides additional source of nutrients

A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. A supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, as for example collagen from chickens or fish. These are also sold individually and in combination, and may be combined with nutrient ingredients. In the United States and Canada, dietary supplements are considered a subset of foods, and are regulated accordingly. The European Commission has also established harmonized rules to help insure that food supplements are safe and properly labeled.

Calcium ions (Ca2+) contribute to the physiology and biochemistry of organisms and the cell. They play an important role in signal transduction pathways, where they act as a second messenger, in neurotransmitter release from neurons, in contraction of all muscle cell types, and in fertilization. Many enzymes require calcium ions as a cofactor, including several of the coagulation factors. Extracellular calcium is also important for maintaining the potential difference across excitable cell membranes, as well as proper bone formation.

Teriparatide pharmaceutical drug

Teriparatide is a recombinant protein form of parathyroid hormone consisting of the first (N-terminus) 34 amino acids, which is the bioactive portion of the hormone. It is an effective anabolic agent used in the treatment of some forms of osteoporosis. It is also occasionally used off-label to speed fracture healing. Teriparatide is identical to a portion of human parathyroid hormone (PTH) and intermittent use activates osteoblasts more than osteoclasts, which leads to an overall increase in bone.

Alendronic acid chemical compound

Alendronic acid, sold under the brand name Fosamax among others, is a bisphosphonate medication used to treat osteoporosis and Paget's disease of bone. It is taken by mouth. Use is often recommended together with vitamin D, calcium supplementation, and lifestyle changes.

Fluoride or fluorine deficiency is a disorder which may cause increased dental caries and possibly osteoporosis, due to a lack of fluoride in the diet. Common dietary sources of fluoride include tea, grape juice, wine, raisins, some seafoods, coffee, and tap water that has been fluoridated. The extent to which the condition truly exists, and its relationship to fluoride poisoning has given rise to some controversy. Fluorine is not considered to be an essential nutrient, but the importance of fluorides for preventing tooth decay is well-recognized, although the effect is predominantly topical. Prior to 1981, the effect of fluorides was thought to be largely systemic and preeruptive, requiring ingestion. Fluoride is considered essential in the development and maintenance of teeth by the American Dental Hygienists' Association. Fluoride is also essential as it incorporates into the teeth to form and harden teeth enamels so that the teeth are more acid resistant as well as more resistant to cavity forming bacteria. Caries-inhibiting effects of fluoride were first seen in 1902 when fluoride in high concentrations was found to stain teeth and prevent tooth decay.

Renal osteodystrophy is currently defined as an alteration of bone morphology in patients with chronic kidney disease (CKD). It is one measure of the skeletal component of the systemic disorder of chronic kidney disease-mineral and bone disorder (CKD-MBD). The term "renal osteodystrophy" was coined in 1943, 60 years after an association was identified between bone disease and renal failure.

Bone resorption The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.

Bone resorption is resorption of bone tissue, that is, the process by which osteoclasts break down the tissue in bones and release the minerals, resulting in a transfer of calcium from bone tissue to the blood.

RANKL protein-coding gene in the species Homo sapiens

Receptor activator of nuclear factor kappa-Β ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is a protein that in humans is encoded by the TNFSF11 gene.

Ibandronic acid chemical compound

Ibandronic acid or ibandronate sodium is a bisphosphonate medication used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia.

Strontium ranelate chemical compound

Strontium ranelate, a strontium(II) salt of ranelic acid, is a medication for osteoporosis marketed as Protelos or Protos by Servier. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA).

Senile osteoporosis, formerly known as osteoporosis type II, has been recently recognized as a geriatric syndrome with a particular pathophysiology.

Femarelle

Femarelle is a dietary supplement that is a mixture of DT56a and flaxseed powder, that may act as a selective estrogen receptor modulator (SERM). In 2008 an application was submitted to the European Food Safety Authority to market Femarelle with a health claim, namely that it can reduce the risk for osteoporosis and other bone disorders; the EFSA found that "the food/constituent for which the claim is made, i.e. Femarelle, has not been sufficiently characterised" and that " a cause and effect relationship has not been established between the consumption of Femarelle and increased BMD, increased bone formation, or decreased risk of osteoporosis or other bone disorders in post-menopausal women."

Vegan nutrition fiber content of foods

Vegan nutrition refers to the nutritional and human health aspects of vegan diets. A well-planned, balanced vegan diet is suitable to meet all recommendations for nutrients in every stage of human life. Improperly planned vegan diets may be deficient in vitamin B12, vitamin D, calcium, iodine, iron, zinc and riboflavin (vitamin B2). Preliminary evidence from clinical research indicates that a vegan diet may lower the risk of cancer.

Eldecalcitol chemical compound

Eldecalcitol is a drug used in Japan for the treatment of osteoporosis. It is an analog of vitamin D. Osteoporosis is a common bone disease among the older generation, with an estimated prevalence of over 200 million people. This condition often results in bone fractures due to abnormally low bone mass density, and is a leading cause of disability, especially among developed countries with longer average life spans. Osteoporosis is more common in women than with men.

Vitamin K2 or menaquinone has nine related compounds, generally subdivided into the short-chain menaquinones (with MK-4 as the most important member) and the long-chain menaquinones, of which MK-7, MK-8 and MK-9 are nutritionally the most recognized.

The human skeletal system is a complex organ in constant equilibrium with the rest of the body. In addition to support and structure of the body, bone is the major reservoir for many minerals and compounds essential for maintaining a healthy pH balance. The deterioration of the body with age renders the elderly particularly susceptible to and affected by poor bone health. Illnesses like osteoporosis, characterized by weakening of the bone’s structural matrix, increases the risk of hip-fractures and other life-changing secondary symptoms. In 2010, over 258,000 people aged 65 and older were admitted to the hospital for hip fractures. Incidence of hip fractures is expected to rise by 12% in America, with a projected 289,000 admissions in the year 2030. Other sources estimate up to 1.5 million Americans will have an osteoporotic-related fracture each year. The cost of treating these people is also enormous, in 1991 Medicare spent an estimated $2.9 billion for treatment and out-patient care of hip fractures, this number can only be expected to rise.

Calcium supplement

Calcium supplements are salts of calcium used in a number of conditions. Supplementation is generally only required when there is not enough calcium in the diet. By mouth they are used to treat and prevent low blood calcium, osteoporosis, and rickets. By injection into a vein they are used for low blood calcium that is resulting in muscle spasms and for high blood potassium or magnesium toxicity.

Bahram H. Arjmandi researcher

Bahram H. Arjmandi is an American nutritionist. He is the Margaret A. Sitton Professor at Florida State University (FSU) and is the founder and Director of the Center for Advancing Exercise and Nutrition Research on Aging (CAENRA). He is a researcher in the fields of functional foods and human health. He was among the first to detect the presence of estrogen receptors in the gut linking the importance of estrogen and estrogen receptors in calcium regulation independent of vitamin D.

References

  1. 1 2 3 Möller, N.P., Scholz-Ahrens, K.E., Roos, N., & Schrezenmeir, J. (2008). Bioactive peptides and proteins from foods: indication for health effects. European Journal of Nutrition, 47(4), 176.
  2. Uenishi, K. (2006). Prevention of osteoporosis by foods and dietary supplements. Prevention of osteoporosis by milk and dairy products. Clinical Calcium, 16(10), 10.
  3. 1 2 Kruger, C.L., Marano, K.M., Morita, Y., Takada, Y., Kawakami, H., Kobayashi, T., Sunaga, M., Furukawa, M., & Kawamura, K. (2007). Safety evaluation of a milk basic protein fraction. Food and Chemical Toxicology, 45, 1301.
  4. 1 2 Goodman, R., Taylor, S., Yamamura, J., Kobayashi, T., Kawakami, H., Kruger, C., & Thompson, G. (2007). Assessment of the potential allergenicity of a Milk Basic Protein fraction. Food and Chemical Toxicology, 45, 1788.
  5. Foster, Tammy; Purnendu C Vasavada (2003). Beverage Quality and Safety. CRC Press. p. 22. ISBN   1-58716-011-0 . Retrieved 2009-03-06.
  6. 1 2 Kawakami, H. (2005). Biological significance of Milk Basic Protein (MBP) for bone health. FSTR, 11, 1.
  7. Itabashi, A. (2006). Prevention of osteoporosis by foods and dietary supplements. Milk basic protein (MBP) increases bone mineral density in young adult women and perimenopausal women. Clinical Calcium, 16(10), 1632.